De Facto wins brief with Sphere Medical to handle PR

De Facto Communications, part of the Bell Pottinger Group, has been appointed by Sphere Medical to raise awareness of its blood chemistry monitoring technology.

Kevin Payne: De Facto co-founder
Kevin Payne: De Facto co-founder

The agency is tasked with promoting the products to medical device manufacturers and anaesthetists working in critical care.

Sphere Medical's patented technology has the scope to improve outcomes among critically ill patients by giving clinicians an accurate picture of each patient's status.

De Facto will aim to build Sphere's reputation through media targeted at medical device companies and the medical journals read by anaesthetists.

De Facto was selected after a four-way pitch.

In addition to media relations, De Facto will also be helping Sphere Medical with its digital marketing.

Strategic direction for the Sphere Medical account will be provided by co-founder Kevin Payne, with associate director Hilary Latham handling day-to-day activities.


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in